All Resources

Access to Medicine • November 17, 2022

Innovative Agreements Framework

Learn more|View

Economic Impact • October 07, 2022

Pre-Budget Consultations in Advance of the 2023 Budget

Learn more|View

Access to Medicine • July 06, 2022

Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response

Learn more|View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

This policy note characterizes Canada’s current testing infrastructure and its limitations, which include that it hinders current and future patient access to the best available treatments….

Learn more|View

January 14, 2022

2022 Ontario Pre-Budget Consultation

Learn more|View

Drugs for Rare Diseases (DRD) • March 26, 2021

Towards a Value-based and Pan-Canadian Rare Disease Strategy

Learn more|View

Access to Medicine • March 06, 2020

Importation of Prescription Drugs; Proposed Rule

Learn more|View

January 30, 2020

2019 Annual Report

Learn more|View

November 01, 2018

Guide to Providing Clinician Input and Feedback with the pCODR Program (2018)

Learn more|View

December 01, 2017

Understanding the Gap: A Pan-Canadian Analysis of Prescription Drug Insurance Coverage

Learn more|View

November 20, 2017

Nanos: Prescription Use Survey Summary

Learn more|View

October 01, 2017

Data Analytics and Members’ Economic Footprint and Impact in Canada

Learn more|View